Literature DB >> 19913200

Role of the GABA(B) receptor in alcohol-seeking and drinking behavior.

Paola Maccioni1, Giancarlo Colombo.   

Abstract

The present paper summarizes experimental data demonstrating the reducing effect of direct agonists and positive allosteric modulators (PAMs) of the gamma-aminobutyric acid(B) (GABA(B)) receptor on different alcohol-related behaviors. Different lines of evidence indicate that direct agonists, including baclofen, effectively suppress acquisition and maintenance of alcohol drinking behavior, relapse-like drinking, and alcohol's reinforcing, rewarding, stimulating, and motivational properties in rats and mice. More recently, the discovery of a positive allosteric modulatory binding site, together with the synthesis of in vivo effective ligands, opened a new avenue of research in GABA(B) pharmacology. Accumulating lines of evidence suggest that PAMs retain baclofen's capcity to suppress alcohol consumption and alcohol's reinforcing and motivational properties in rats; these effects occur at doses far from those producing behavioral toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913200     DOI: 10.1016/j.alcohol.2009.09.030

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  38 in total

1.  Growth hormone responses to GABAB receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects.

Authors:  Royce Lee; Berdine Chong; Emil Coccaro
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

2.  Strain dependent gene expression and neurochemical levels in the brain of zebrafish: focus on a few alcohol related targets.

Authors:  Y Pan; D Chatterjee; R Gerlai
Journal:  Physiol Behav       Date:  2012-02-01

Review 3.  Future pharmacological treatments for substance use disorders.

Authors:  Ariadna Forray; Mehmet Sofuoglu
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 4.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

5.  Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection.

Authors:  L Leggio; A Ferrulli; A Zambon; F Caputo; G A Kenna; R M Swift; G Addolorato
Journal:  Addict Behav       Date:  2011-12-27       Impact factor: 3.913

Review 6.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

Review 7.  The genetics of behavioral alcohol responses in Drosophila.

Authors:  Aylin R Rodan; Adrian Rothenfluh
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

Review 8.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

9.  Regulator of G protein signaling 6 is a critical mediator of both reward-related behavioral and pathological responses to alcohol.

Authors:  Adele Stewart; Biswanath Maity; Simon P Anderegg; Chantal Allamargot; Jianqi Yang; Rory A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

10.  Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior.

Authors:  Reginald Cannady; Jennifer A Rinker; Sudarat Nimitvilai; John J Woodward; Patrick J Mulholland
Journal:  Handb Exp Pharmacol       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.